ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 58 filers reported holding ONCOCYTE CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,316 | +10.4% | 15,000 | 0.0% | 0.00% | – |
| Q4 2022 | $4,814 | -56.2% | 15,000 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -15.4% | 15,000 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -40.9% | 15,000 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | -33.3% | 15,000 | 0.0% | 0.00% | – |
| Q4 2021 | $33,000 | -57.7% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $78,000 | +116.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +71.4% | 15,000 | 0.0% | 0.00% | – |
| Q3 2020 | $21,000 | -27.6% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $29,000 | -21.6% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $37,000 | +8.8% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $34,000 | +6.2% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $32,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,596,680 | $16,725,000 | 2.33% |
| Artal Group S.A. | 150,000 | $698,000 | 0.01% |
| Destination Wealth Management | 29,656 | $138,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $674,000 | 0.01% |
| IHT Wealth Management, LLC | 563 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 695 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 44,048 | $205,000 | 0.00% |
| Vantage Investment Advisors, LLC | 25 | $0 | 0.00% |
| UBS Group AG | 5,204 | $24,000 | 0.00% |
| Legal & General Group Plc | 384 | $2,000 | 0.00% |